NCT06735001

Identification of the Metabolic Signature of Atrial Fibrillation for Personalized Prevention

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2025-03-10Est. Completion: 2029-10

Enrollment target: 400 participants

Locations

Contact

Cardiac ArrhythmiaDiagnostic/Monitoring Devices Related to Adverse IncidentsAtrial Fibrillation (AF)

Heart rhythm disorders are common and significantly impact the lives of those affected and their families. The main prob…

Calgary, CanadaEst. completion Dec 31, 2026

Atrial FibrillationOral AnticoagulationStrokeImplant

Patients with atrial fibrillation (AF) who have had a prior stroke are at very high risk of recurrent ischemic stroke. A…

Rockford, United StatesEst. completion Dec 20, 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.